BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20831164)

  • 1. Chemoselective attachment of small molecule effector functionality to human adenoviruses facilitates gene delivery to cancer cells.
    Banerjee PS; Ostapchuk P; Hearing P; Carrico I
    J Am Chem Soc; 2010 Oct; 132(39):13615-7. PubMed ID: 20831164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altering adenoviral tropism via click modification with ErbB specific ligands.
    Oum YH; Carrico IS
    Bioconjug Chem; 2012 Jul; 23(7):1370-6. PubMed ID: 22681483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unnatural amino acid incorporation onto adenoviral (Ad) coat proteins facilitates chemoselective modification and retargeting of Ad type 5 vectors.
    Banerjee PS; Ostapchuk P; Hearing P; Carrico IS
    J Virol; 2011 Aug; 85(15):7546-54. PubMed ID: 21613404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoselective modification of viral surfaces via bioorthogonal click chemistry.
    Rubino FA; Oum YH; Rajaram L; Chu Y; Carrico IS
    J Vis Exp; 2012 Aug; (66):e4246. PubMed ID: 22929552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoselective modification of viral proteins bearing metabolically introduced "clickable" amino acids and sugars.
    Banerjee PS; Carrico IS
    Methods Mol Biol; 2011; 751():55-66. PubMed ID: 21674325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system.
    Stoff-Khalili MA; Stoff A; Rivera AA; Mathis JM; Everts M; Wang M; Kawakami Y; Waehler R; Mathews QL; Yamamoto M; Rocconi RP; Siegal GP; Richter DF; Dall P; Zhu ZB; Curiel DT
    Cancer Biol Ther; 2005 Nov; 4(11):1203-10. PubMed ID: 16177567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic efficacy of oncolytic adenoviruses in imagable orthotopic models of hormone refractory metastatic breast cancer.
    Ranki T; Särkioja M; Hakkarainen T; von Smitten K; Kanerva A; Hemminki A
    Int J Cancer; 2007 Jul; 121(1):165-74. PubMed ID: 17315187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retargeted adenoviruses for radiation-guided gene delivery.
    Kaliberov SA; Kaliberova LN; Yan H; Kapoor V; Hallahan DE
    Cancer Gene Ther; 2016 Sep; 23(9):303-14. PubMed ID: 27492853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and bone marrow purging.
    Seth P; Brinkmann U; Schwartz GN; Katayose D; Gress R; Pastan Ira ; Cowan K
    Cancer Res; 1996 Mar; 56(6):1346-51. PubMed ID: 8640824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An adenoviral vector containing an arg-gly-asp (RGD) motif in the fiber knob enhances protein product levels from transgenes refractory to expression.
    Campbell M; Qu S; Wells S; Sugandha H; Jensen RA
    Cancer Gene Ther; 2003 Jul; 10(7):559-70. PubMed ID: 12833136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor β Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models.
    Xu W; Yang Y; Hu Z; Head M; Mangold KA; Sullivan M; Wang E; Saha P; Gulukota K; Helseth DL; Guise T; Prabhkar BS; Kaul K; Schreiber H; Seth P
    Hum Gene Ther; 2020 Aug; 31(15-16):863-880. PubMed ID: 32394753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted and armed oncolytic adenovirus via chemoselective modification.
    Banerjee PS; Zuniga ES; Ojima I; Carrico IS
    Bioorg Med Chem Lett; 2011 Sep; 21(17):4985-8. PubMed ID: 21669527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and in vitro and in vivo evaluation of a cationic emulsion as a vehicle for improving adenoviral gene transfer.
    Kim SY; Lee SJ; Lim SJ
    Int J Pharm; 2014 Nov; 475(1-2):49-59. PubMed ID: 25138255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel adenoviral gene delivery system targeted against head and neck cancer.
    Li D; Guang W; Abuzeid WM; Roy S; Gao GP; Sauk JJ; O'Malley BW
    Laryngoscope; 2008 Apr; 118(4):650-8. PubMed ID: 18176343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive imaging for evaluation of the systemic delivery of capsid-modified adenoviruses in an orthotopic model of advanced lung cancer.
    Sarkioja M; Kanerva A; Salo J; Kangasniemi L; Eriksson M; Raki M; Ranki T; Hakkarainen T; Hemminki A
    Cancer; 2006 Oct; 107(7):1578-88. PubMed ID: 16948124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors.
    Hakkarainen T; Särkioja M; Lehenkari P; Miettinen S; Ylikomi T; Suuronen R; Desmond RA; Kanerva A; Hemminki A
    Hum Gene Ther; 2007 Jul; 18(7):627-41. PubMed ID: 17604566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice.
    Romanczuk H; Galer CE; Zabner J; Barsomian G; Wadsworth SC; O'Riordan CR
    Hum Gene Ther; 1999 Nov; 10(16):2615-26. PubMed ID: 10566889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled by alpha-lactalbumin promoter.
    Li X; Zhang J; Gao H; Vieth E; Bae KH; Zhang YP; Lee SJ; Raikwar S; Gardner TA; Hutchins GD; VanderPutten D; Kao C; Jeng MH
    Mol Cancer Ther; 2005 Dec; 4(12):1850-9. PubMed ID: 16373700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviruses with an αvβ integrin targeting moiety in the fiber shaft or the HI-loop increase tumor specificity without compromising antitumor efficacy in magnetic resonance imaging of colorectal cancer metastases.
    Lavilla-Alonso S; Bauerschmitz G; Abo-Ramadan U; Halavaara J; Escutenaire S; Diaconu I; Tatlisumak T; Kanerva A; Hemminki A; Pesonen S
    J Transl Med; 2010 Aug; 8():80. PubMed ID: 20727221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.